nanotech investing Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
nanotech investing Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
nanotech investing Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
nanotech investing Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
nanotech investing Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters' Option to Purchase Additional Shares
nanotech investing Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
Aventis Energy Intersects Anomalous Radioactivity in Multiple Drill Holes at the Corvo Uranium Project and Concludes Inaugural Drill Program
Standard Uranium Intersects Anomalous Radioactivity in Multiple Drill Holes at the Corvo Uranium Project; Concludes Inaugural Drill Program
